2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline

Context Patients with atrial fibrillation (ACC summary of the 2023 guideline)

Recipient

Recipient not specified

Population

Patients with atrial fibrillation. The ACC summary gives no age limits and, apart from the exceptions each claim names, no exclusions.

Care setting

Not stated in the ACC summary.

Geography

Not stated in the ACC summary (issued by American societies; jurisdiction not verified)

Life stage

Not stated in the ACC summary

Gestational age

Not reported

Postnatal age

Not reported

Follow-up

Not applicable (guideline context)

• Recommendation Guidance Certainty not assessed

  An ACC summary of the 2023 ACC/AHA atrial fibrillation guideline says that for patients whose estimated yearly chance of a stroke or thromboembolic event is 2% or more, therapy to lower stroke risk should follow that thromboembolic risk, whatever the AF pattern (paroxysmal, persistent, long-standing persistent and permanent alike).

  Source problem. A cited source is corrected. Check the sources before relying on this claim.

  Applies to Recipient not specified

  • Patients with atrial fibrillation. The ACC summary gives no age limits and, apart from the exceptions each claim names, no exclusions.
  • Not stated in the ACC summary.
  • Not stated in the ACC summary (issued by American societies; jurisdiction not verified)
  • Not stated in the ACC summary
  • Gestational age Not reported
  • Postnatal age Not reported

  Follow-up Not applicable (guideline context)

  Certainty method

  Not assessed

  Limitations

  The source is the ACC key-perspectives summary of the guideline (ACC content, hash only), not the guideline text. The summary says stroke-reducing therapy, not oral anticoagulants by name, in this statement, so no recommendation record is written for it. It prints no class of recommendation for this statement, and it gives the treatment for lower-risk patients in text that could not be quoted. PubMed lists three corrections to the guideline (2024-01-02, 2024-02-27 and 2024-06-11); their text was not read, so it is not known whether they change anything stated here.

  Last checked

  2026-10-15

  Next evidence check due

  Not scheduled

  Sources and citations (2)

  1. Supports 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

     Guideline · Circulation · Edition Published in Circulation 149(1):e1-e156 (issue date 2024-01-02; electronic publication 2023-11-30). PubMed abstract and bibliographic data only. PMC lists an author manuscript (PMC11095842) that is not in the PMC Open Access subset, so it was not fetched. The guideline text was not read. PubMed lists 3 corrections to the guideline; their text was not read. The same source also holds a snapshot of the ACC key-perspectives summary page (dated Nov 30, 2023), an ACC summary and not the guideline text. In the page markup some less-than symbols hide the text that follows them, so only passages free of such symbols are quoted. The publisher field is the journal title as PubMed gives it. · Published 2024-01-02 · DOI: 10.1161/CIR.0000000000001193 · PMID: 38033089 · PMCID: PMC11095842

     Locator

     Key perspective 4, sentence 2, fragments 1 to 3

     How it applies

     Stroke-reducing therapy follows thromboembolic risk, not AF pattern, at an annual risk of 2% or more.

     Retrieved

     2026-10-15T13:52:56Z

     Source effective date

     Not reported

     Source state

     Corrected

     Snapshot hash

     351ef6a153a9922b720e0ea62e3c8ccb64abd9945012b3992bb58528d3446453

     Reuse basis

     PubMed record and ACC page. PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. ACC web page fetched with a plain Mozilla/5.0 user agent on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The ACC's reuse terms were not read, so public text is cite_only: public pages state the summary in the atlas's own words, with a citation and a link, and use no ACC wording. Quote rows are short evidence fragments for the reviewer.

  2. Background 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

     Guideline · Circulation · Edition Published in Circulation 149(1):e1-e156 (issue date 2024-01-02; electronic publication 2023-11-30). PubMed abstract and bibliographic data only. PMC lists an author manuscript (PMC11095842) that is not in the PMC Open Access subset, so it was not fetched. The guideline text was not read. PubMed lists 3 corrections to the guideline; their text was not read. The same source also holds a snapshot of the ACC key-perspectives summary page (dated Nov 30, 2023), an ACC summary and not the guideline text. In the page markup some less-than symbols hide the text that follows them, so only passages free of such symbols are quoted. The publisher field is the journal title as PubMed gives it. · Published 2024-01-02 · DOI: 10.1161/CIR.0000000000001193 · PMID: 38033089 · PMCID: PMC11095842

     Locator

     CommentsCorrectionsList, three ErratumIn entries

     How it applies

     Shows that corrections exist. What they change is unknown.

     Retrieved

     2026-10-15T13:48:58Z

     Source effective date

     Not reported

     Source state

     Corrected

     Snapshot hash

     3ee3998a9178e8f21223e2388261924207d5e1f8fb19bf34e8355e11eb2c07a9

     Reuse basis

     PubMed record and ACC page. PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. ACC web page fetched with a plain Mozilla/5.0 user agent on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The ACC's reuse terms were not read, so public text is cite_only: public pages state the summary in the atlas's own words, with a citation and a link, and use no ACC wording. Quote rows are short evidence fragments for the reviewer.

• Recommendation Guidance Certainty not assessed

  An ACC summary of the 2023 ACC/AHA atrial fibrillation guideline says the guideline endorses using a validated clinical risk score to estimate stroke and thromboembolism risk; it gives CHA2DS2-VASc, ATRIA and GARFIELD-AF as examples.

  Source problem. A cited source is corrected. Check the sources before relying on this claim.

  Applies to Recipient not specified

  • Patients with atrial fibrillation. The ACC summary gives no age limits and, apart from the exceptions each claim names, no exclusions.
  • Not stated in the ACC summary.
  • Not stated in the ACC summary (issued by American societies; jurisdiction not verified)
  • Not stated in the ACC summary
  • Gestational age Not reported
  • Postnatal age Not reported

  Follow-up Not applicable (guideline context)

  Certainty method

  Not assessed

  Limitations

  The source is the ACC key-perspectives summary of the guideline (ACC content, hash only), not the guideline text. The summary names three scores as examples and does not rank them. It gives no class of recommendation for this statement. PubMed lists three corrections to the guideline (2024-01-02, 2024-02-27 and 2024-06-11); their text was not read, so it is not known whether they change anything stated here.

  Last checked

  2026-10-15

  Next evidence check due

  Not scheduled

  Sources and citations (2)

  1. Supports 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

     Guideline · Circulation · Edition Published in Circulation 149(1):e1-e156 (issue date 2024-01-02; electronic publication 2023-11-30). PubMed abstract and bibliographic data only. PMC lists an author manuscript (PMC11095842) that is not in the PMC Open Access subset, so it was not fetched. The guideline text was not read. PubMed lists 3 corrections to the guideline; their text was not read. The same source also holds a snapshot of the ACC key-perspectives summary page (dated Nov 30, 2023), an ACC summary and not the guideline text. In the page markup some less-than symbols hide the text that follows them, so only passages free of such symbols are quoted. The publisher field is the journal title as PubMed gives it. · Published 2024-01-02 · DOI: 10.1161/CIR.0000000000001193 · PMID: 38033089 · PMCID: PMC11095842

     Locator

     Key perspective 3, sentence 1

     How it applies

     A validated clinical risk score is endorsed; three examples.

     Retrieved

     2026-10-15T13:52:56Z

     Source effective date

     Not reported

     Source state

     Corrected

     Snapshot hash

     351ef6a153a9922b720e0ea62e3c8ccb64abd9945012b3992bb58528d3446453

     Reuse basis

     PubMed record and ACC page. PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. ACC web page fetched with a plain Mozilla/5.0 user agent on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The ACC's reuse terms were not read, so public text is cite_only: public pages state the summary in the atlas's own words, with a citation and a link, and use no ACC wording. Quote rows are short evidence fragments for the reviewer.

  2. Background 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

     Guideline · Circulation · Edition Published in Circulation 149(1):e1-e156 (issue date 2024-01-02; electronic publication 2023-11-30). PubMed abstract and bibliographic data only. PMC lists an author manuscript (PMC11095842) that is not in the PMC Open Access subset, so it was not fetched. The guideline text was not read. PubMed lists 3 corrections to the guideline; their text was not read. The same source also holds a snapshot of the ACC key-perspectives summary page (dated Nov 30, 2023), an ACC summary and not the guideline text. In the page markup some less-than symbols hide the text that follows them, so only passages free of such symbols are quoted. The publisher field is the journal title as PubMed gives it. · Published 2024-01-02 · DOI: 10.1161/CIR.0000000000001193 · PMID: 38033089 · PMCID: PMC11095842

     Locator

     CommentsCorrectionsList, three ErratumIn entries

     How it applies

     Shows that corrections exist. What they change is unknown.

     Retrieved

     2026-10-15T13:48:58Z

     Source effective date

     Not reported

     Source state

     Corrected

     Snapshot hash

     3ee3998a9178e8f21223e2388261924207d5e1f8fb19bf34e8355e11eb2c07a9

     Reuse basis

     PubMed record and ACC page. PubMed record fetched through NCBI E-utilities on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. Bibliographic metadata and short quotations from the PubMed abstract, under 25 words each. The full text was not redistributed and the societies' reuse terms were not reviewed. ACC web page fetched with a plain Mozilla/5.0 user agent on 2026-10-15. Only the hash of the bytes is kept; nothing is committed. The ACC's reuse terms were not read, so public text is cite_only: public pages state the summary in the atlas's own words, with a citation and a link, and use no ACC wording. Quote rows are short evidence fragments for the reviewer.